Analogue-based Drug Discovery III


  • János Fischer is a Senior Research Scientist at Richter Plc., Budapest, Hungary
  • Prof. Dr. C. Robin Ganellin, University College London. UK
  • Prof. Dr. David P. Rotella, Montclair State University, US


Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs.
The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and — together with the previous volumes — constitutes the first systematic approach to drug analogue development.


“The book’s 15 chapters and 40 authors from 9 countries bring important, successful drug discoveries closer to medicinal chemists and all who are interested in the history of drug discoveries.  The major part of the chapters are written by key inventors.”  (Chemistry International, 1 January 2013)

Book details

  • Publisher: Wiley-VCH; 1 edition (January 29, 2013)
  • Language: English
  • ISBN-10: 3527330739
  • ISBN-13: 978-3527330737


This content is for gold members only. Log In or Register to see
Tags: , , , , , , , , , ,

Comments are closed.